Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58
Closed -$2.66K 698
2026
Q1
$2.66K Sell
58
-100
-63% -$5.78K ﹤0.01% 458
2025
Q4
$11.8K Buy
+158
New +$11.4K ﹤0.01% 228
2025
Q1
Sell
-43
Closed -$2.62K 331
2024
Q4
$2.62K Buy
43
+29
+207% +$1.61K ﹤0.01% 441
2024
Q3
$571 Buy
+14
New +$465 ﹤0.01% 342
2024
Q2
Sell
-24
Closed -$894 196
2024
Q1
$894 Buy
+24
New +$958 ﹤0.01% 201
2023
Q3
Sell
-65
Closed -$996 399
2023
Q2
$996 Buy
+65
New +$862 ﹤0.01% 475
2023
Q1
Sell
-880
Closed -$8.51K 314
2022
Q4
$8.51K Buy
880
+780
+780% +$11.8K ﹤0.01% 486
2022
Q3
$2K Sell
100
-187
-65% -$4.89K ﹤0.01% 471
2022
Q2
$5K Buy
287
+39
+16% +$1.06K ﹤0.01% 289
2022
Q1
$11K Buy
+248
New +$13K ﹤0.01% 155

Other funds holding AFRM

Elequin Capital's AFRM Position: Q2 2026 in Review

Elequin Capital sold out of Affirm (AFRM) in Q2 2026, closing a stake of 58 shares — an estimated $2.66K sold.

Elequin Capital first reported a position in AFRM in Q1 2022 and held it in 10 quarters. The position peaked at $11.8K in Q4 2025. 660 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Elequin Capital reported no remaining Affirm position as of Q2 2026 after selling out during the quarter.
  • Elequin Capital sold 58 Affirm shares in Q2 2026, an estimated $2.66K.
  • Elequin Capital first reported a position in Affirm in Q1 2022 and held it in 10 quarters.
  • Elequin Capital's Affirm position peaked at $11.8K in Q4 2025.
  • 660 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.